Minjuvi (tafasitamab)

pCPA File Number: 22052
Negotiation Status:
Concluded with an LOI
in combination with lenalidomide for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified including DLBCL arising from low grade lymphoma, who are not eligible for autologous stem cell transplant
Incyte Biosciences Canada Corporation
CADTH Project Number:
pCPA Engagement Letter Issued:
Negotiation Process Concluded: